Evaluation of Drug Buying Process for Metastatic Colorectal Cancer (CRC) treatment among Healthcare
Business Services, Market Intelligence
Client: German Pharmaceuticals
Treatment on mCRC (metastatic colorectal cancer) varied among the industry practitioners. The Client would like to understand its buying process, current customers’ usage and attitude. This is to develop marketing strategies specifically for product launching initiatives.
To fully understand the current mCRC management and treatment pattern
To identify the drivers for treatment and brand preferences
To gather perceptions of new mCRC agents currently in development
To anticipate potential use of those new agents and their impact on current treatment algorithms
Our Approach and Work:
We worked with industry experts to collate latest industry news as input for survey content design. In-depth interviews were conducted with oncologists from both public and private sectors, followed by interpretation of research findings using qualitative and quantitative approach.
Outcome and Business Impact:
We delivered updated, in-depth customer feedback based on primary resources. We also provided an insightful analysis on current buying process and factors that influenced the brand preference. The results were translated into immediate action plans for Client’s new product launching initiatives.
, Market Intelligence